“Unfortunately, there is a large gap between theory and the real situation on the market. Researches consider a leu-euro exchange rate which differs from the one applied in real market transactions, as well as medicine prices in drugstores, which include distribution margins (…),” Dragos Damian, president of the Association of Generic Medicine Producers in Romania, or APMGR, said in a press release Monday.
According to Damian, market researches should consider the clawback tax, which is paid only by medicine producers. Surveys should exclude parallel exports, estimated at 15%-20% of the original drug market, and should consider delays in refunding bills.
APMGR pointed out that uncertainties on the pharmaceutical market, such as the future clawback tax formula and the new formula to compute drug prices, prevent producers from making medium- and long-term business plans.
Damian said recently the local pharmaceutical market shrank significantly in the first half of the year, considering producer prices.
Market research company Cegedim said Friday the Romanian pharmaceutical market climbed 3.5% in the first six months of 2013 to EUR1.34 billion. Cegedim said in its report data concern drugstore sales.
According to IMS Health data, cited by Ziarul Financiar, the local medicine market rose 7% in the first half to EUR1.4 billion.